Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

The Indian Pharmaceutical Alliance (IPA) has welcomed the US administration's decision to exempt pharmaceuticals from the ...

The second executive at a drugmaker said his company was "stockpiling" in the United States, the pharma industry's biggest ...

Pharmaceuticals, among other products, will not be subject to the reciprocal tariffs, according to a White House fact sheet ...

The US exempts pharmaceuticals from reciprocal tariffs, underscoring the vital role of generic medicines in global healthcare ...

Indian drugmakers relieved as Trump exempts pharmaceuticals from tariffs, highlighting critical role of generic medicines in ...

Tariffs are one way for Donald Trump to achieve tax cuts, and Irish-based pharma industry may be a golden goose ready for ...

US President Donald Trump on Thursday exempted imports of pharmaceuticals, energy and certain other minerals from the scope ...

The pharmaceutical industry isn’t happy about President Donald Trump’s trade war and is reportedly lobbying the President to slow down drug ...

Europe's pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by President Donald Trump fade.

In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.